Clinical Publications

GI Dynamics enrolls first patient in pivotal EndoBarrier trial

Minimally-Invasive, Innovative Therapy Used for Treating Type 2 Diabetes and Obesity U-M expert discusses an upcoming clinical trial involving a new non-invasive, endoscopic weight-loss procedure called the EndoBarrier®.

GI Dynamics continues to turn its story around with UK study.

The EndoBarrier Device for Type 2 Diabetes: What You Need to Know

EndoBarrier – What is the EndoBarrier?

New Devices to Combat Obesity, from Three Boston-Area Firms

GI Dynamics wins FDA nod for pivotal US EndoBarrier trial

Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2

New EndoBarrier tech looks set to rival traditional gastric bypass surgery.

The Guardian reports: “Device that helps obese diabetic lose weight ‘should be rolled out across NHS’”

ITV news reports: “Gastric bypass alternative helps obese people lose two stone”

Patient hails ‘life-changing’ EndoBarrier diabetes device. This article also appeared in the UK in the Wirral Globe, Epsom Guardian, Yeovil Express, Maldon & Burnham Standard and other regional

The Daily Mail writes: “Patient hails ‘life-changing’ EndoBarrier diabetes device”

The Daily Express writes: ”Diabetes news: Type 2 sufferers could shed more than TWO STONE with this device”

Device to treat type 2 diabetes should be used on NHS.

Diabetes.co.uk, a community website, health platform and patient support network that has developed into Europe’s largest community for people with diabetes or concerned about diabetes writes: New EndoBarrier

GI Dynamics Scientific Advisor Francesco Rubino, MD of King’s College London, featured in Scientific American, discussing effective treatments for type 2 diabetes.

EndoBarrier treatment could help NHS treat type 2.